Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Shares Outstanding (2016 - 2025)

Macrogenics (MGNX) has disclosed Shares Outstanding for 14 consecutive years, with $63.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 0.79% to $63.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63.3 million through Dec 2025, up 0.79% year-over-year, with the annual reading at $63.3 million for FY2025, 0.79% up from the prior year.
  • Shares Outstanding for Q4 2025 was $63.3 million at Macrogenics, roughly flat from $63.3 million in the prior quarter.
  • The five-year high for Shares Outstanding was $63.3 million in Q4 2025, with the low at $60.0 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $62.0 million, with a median of $62.0 million recorded in 2023.
  • The sharpest move saw Shares Outstanding increased 12.68% in 2021, then increased 0.34% in 2022.
  • Over 5 years, Shares Outstanding stood at $61.3 million in 2021, then grew by 0.64% to $61.7 million in 2022, then rose by 0.6% to $62.1 million in 2023, then increased by 1.21% to $62.8 million in 2024, then increased by 0.79% to $63.3 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $63.3 million, $63.3 million, and $63.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.